Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 194

1.

MicroRNA-21 inhibition enhances in vitro chemosensitivity of temozolomide-resistant glioblastoma cells.

Wong ST, Zhang XQ, Zhuang JT, Chan HL, Li CH, Leung GK.

Anticancer Res. 2012 Jul;32(7):2835-41.

PMID:
22753745
2.

miR-128 and miR-149 enhance the chemosensitivity of temozolomide by Rap1B-mediated cytoskeletal remodeling in glioblastoma.

She X, Yu Z, Cui Y, Lei Q, Wang Z, Xu G, Xiang J, Wu M, Li G.

Oncol Rep. 2014 Sep;32(3):957-64. doi: 10.3892/or.2014.3318.

PMID:
25017996
3.
4.

Targeting miR-381-NEFL axis sensitizes glioblastoma cells to temozolomide by regulating stemness factors and multidrug resistance factors.

Wang Z, Yang J, Xu G, Wang W, Liu C, Yang H, Yu Z, Lei Q, Xiao L, Xiong J, Zeng L, Xiang J, Ma J, Li G, Wu M.

Oncotarget. 2015 Feb 20;6(5):3147-64.

5.

MicroRNA-21 inhibitor sensitizes human glioblastoma U251 stem cells to chemotherapeutic drug temozolomide.

Zhang S, Wan Y, Pan T, Gu X, Qian C, Sun G, Sun L, Xiang Y, Wang Z, Shi L.

J Mol Neurosci. 2012 Jun;47(2):346-56. doi: 10.1007/s12031-012-9759-8.

PMID:
22528454
6.

Nanoparticle-Delivered Antisense MicroRNA-21 Enhances the Effects of Temozolomide on Glioblastoma Cells.

Ananta JS, Paulmurugan R, Massoud TF.

Mol Pharm. 2015 Dec 7;12(12):4509-17. doi: 10.1021/acs.molpharmaceut.5b00694.

PMID:
26559642
7.

The histone demethylase KDM5A is a key factor for the resistance to temozolomide in glioblastoma.

Banelli B, Carra E, Barbieri F, Würth R, Parodi F, Pattarozzi A, Carosio R, Forlani A, Allemanni G, Marubbi D, Florio T, Daga A, Romani M.

Cell Cycle. 2015;14(21):3418-29. doi: 10.1080/15384101.2015.1090063.

8.

MiR-21 protected human glioblastoma U87MG cells from chemotherapeutic drug temozolomide induced apoptosis by decreasing Bax/Bcl-2 ratio and caspase-3 activity.

Shi L, Chen J, Yang J, Pan T, Zhang S, Wang Z.

Brain Res. 2010 Sep 17;1352:255-64. doi: 10.1016/j.brainres.2010.07.009.

PMID:
20633539
9.

MicroRNA-125b-2 confers human glioblastoma stem cells resistance to temozolomide through the mitochondrial pathway of apoptosis.

Shi L, Zhang S, Feng K, Wu F, Wan Y, Wang Z, Zhang J, Wang Y, Yan W, Fu Z, You Y.

Int J Oncol. 2012 Jan;40(1):119-29. doi: 10.3892/ijo.2011.1179.

PMID:
21879257
10.

miR-20a mediates temozolomide-resistance in glioblastoma cells via negatively regulating LRIG1 expression.

Wei J, Qi X, Zhan Q, Zhou D, Yan Q, Wang Y, Mo L, Wan Y, Xie D, Xie J, Yang S.

Biomed Pharmacother. 2015 Apr;71:112-8. doi: 10.1016/j.biopha.2015.01.026.

PMID:
25960225
11.

Inhibition of GSH synthesis potentiates temozolomide-induced bystander effect in glioblastoma.

Kohsaka S, Takahashi K, Wang L, Tanino M, Kimura T, Nishihara H, Tanaka S.

Cancer Lett. 2013 Apr 30;331(1):68-75. doi: 10.1016/j.canlet.2012.12.005.

PMID:
23246370
12.

microRNA expression pattern modulates temozolomide response in GBM tumors with cancer stem cells.

Tezcan G, Tunca B, Bekar A, Preusser M, Berghoff AS, Egeli U, Cecener G, Ricken G, Budak F, Taskapılıoglu MO, Kocaeli H, Tolunay S.

Cell Mol Neurobiol. 2014 Jul;34(5):679-92. doi: 10.1007/s10571-014-0050-0.

PMID:
24691539
13.

miR-181 subunits enhance the chemosensitivity of temozolomide by Rap1B-mediated cytoskeleton remodeling in glioblastoma cells.

She X, Yu Z, Cui Y, Lei Q, Wang Z, Xu G, Luo Z, Li G, Wu M.

Med Oncol. 2014 Apr;31(4):892. doi: 10.1007/s12032-014-0892-9.

PMID:
24573637
14.

Temozolomide resistance in glioblastoma occurs by miRNA-9-targeted PTCH1, independent of sonic hedgehog level.

Munoz JL, Rodriguez-Cruz V, Ramkissoon SH, Ligon KL, Greco SJ, Rameshwar P.

Oncotarget. 2015 Jan 20;6(2):1190-201.

15.

DNMT1 mediates chemosensitivity by reducing methylation of miRNA-20a promoter in glioma cells.

Zhou D, Wan Y, Xie D, Wang Y, Wei J, Yan Q, Lu P, Mo L, Xie J, Yang S, Qi X.

Exp Mol Med. 2015 Sep 4;47:e182. doi: 10.1038/emm.2015.57.

16.

EFEMP1 induces γ-secretase/Notch-mediated temozolomide resistance in glioblastoma.

Hiddingh L, Tannous BA, Teng J, Tops B, Jeuken J, Hulleman E, Boots-Sprenger SH, Vandertop WP, Noske DP, Kaspers GJ, Wesseling P, Wurdinger T.

Oncotarget. 2014 Jan 30;5(2):363-74.

17.

miR-195, miR-455-3p and miR-10a( *) are implicated in acquired temozolomide resistance in glioblastoma multiforme cells.

Ujifuku K, Mitsutake N, Takakura S, Matsuse M, Saenko V, Suzuki K, Hayashi K, Matsuo T, Kamada K, Nagata I, Yamashita S.

Cancer Lett. 2010 Oct 28;296(2):241-8. doi: 10.1016/j.canlet.2010.04.013.

PMID:
20444541
18.

MicroRNA profiling of Chinese primary glioblastoma reveals a temozolomide-chemoresistant subtype.

Yan W, Liu Y, Yang P, Wang Z, You Y, Jiang T.

Oncotarget. 2015 May 10;6(13):11676-82.

19.

miR-487b-5p Regulates Temozolomide Resistance of Lung Cancer Cells Through LAMP2-Medicated Autophagy.

Bao L, Lv L, Feng J, Chen Y, Wang X, Han S, Zhao H.

DNA Cell Biol. 2016 Aug;35(8):385-92. doi: 10.1089/dna.2016.3259.

PMID:
27097129
20.

miR-125b controls apoptosis and temozolomide resistance by targeting TNFAIP3 and NKIRAS2 in glioblastomas.

Haemmig S, Baumgartner U, Glück A, Zbinden S, Tschan MP, Kappeler A, Mariani L, Vajtai I, Vassella E.

Cell Death Dis. 2014 Jun 5;5:e1279. doi: 10.1038/cddis.2014.245.

Supplemental Content

Support Center